Jeronselvein Successfully Concludes 'PDRN Hands-On Course'
Jeronselvein, a company specializing in the production of prescription drugs, announced on December 1 that it has successfully concluded its 'PDRN Total Hands-On Course' seminar to positive reviews.
This seminar was designed to enhance practical skills in regenerative dentistry treatments utilizing polynucleotides (PDRN). Participants focused on hands-on training that reflected clinical environments, with an emphasis on injection techniques applicable in dentistry, dermatology, and temporomandibular disorder (TMD) fields.
The seminar featured in-depth lectures by leading experts in each field, including Lim Jongwon (Director of Best Dental Clinic), Seol Wonseok (Director of Apple Dental Clinic), Yoon Jongil (Vice President of the PDRN Immuno-Regenerative Dentistry Research Society and Director of Yeon Dental Clinic), Kim Hyungjun (Director of OFP Oral Medicine Dental Clinic), Kwon Yongdae (Professor at Kyung Hee University Dental Hospital), and Lee Seonjeong (Director of Yonsei SK Dental Clinic).
The company explained that the seminar, which shared strategies to maximize the effectiveness of PDRN as well as various clinical application cases and procedural experiences, has attracted significant attention in the dental community, with each session reaching capacity early.
Yoon Jongil, Vice President of the PDRN Immuno-Regenerative Dentistry Research Society and Director of Yeon Dental Clinic, stated, "PDRN is being rapidly applied to a variety of dental and dermatological procedures based on its anti-inflammatory and regenerative properties. This hands-on course was especially meaningful as it allowed medical professionals to share treatment protocols that can be immediately implemented in clinical practice."
Kim Deokgyu, CEO of Jeronselvein, said, "The field of regenerative dentistry is advancing rapidly, and accurate procedural training directly translates into better treatment outcomes. Jeronselvein will continue to expand specialized education to further enhance the clinical applicability of PDRN-based regenerative treatments."
Hot Picks Today
"Buy on Black Monday"... Japan's Nomura Forecasts 590,000 for Samsung, 4 Million for SK hynix
- "Plunged During the War, Now Surging Again"... The Real Reason Behind the 6% One-Day Silver Market Rally [Weekend Money]
- "We're Now Earning 10 Million Won a Month"... Semiconductor Boom Drives Performance Bonuses at Major Electronic Component Firms
- 'Bond King' Gundlach: "Rate Cuts Impossible... CPI Could Rise to 4%"
- Experts Are Already Watching Closely..."Target Stock Price 970,000 Won" Now Only the Uptrend Remains [Weekend Money]
Meanwhile, all participants in this PDRN Total Hands-On Course, which was conducted through pre-registration, were awarded certificates of completion.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.